Switzerland buys Pfizer's COVID-19 antiviral Paxlovid
Tweet
Share
E-mail
FILE PHOTO: Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. REUTERS/Jennifer Lorenzini/File Photo
BERLIN (Reuters) - Switzerland signed a contract to buy Pfizer's anti-viral drug Paxlovid to treat Covid-19, it said on Friday.
The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.
(Reporting by Kirsti Knolle, Editing by Miranda Murray)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Why this strategist thinks longer-term outlook for stocks is "unfavorable"
- BofA tracks building products sales momentum in second quarter
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
